Kijimea IBS Pro 10 capsules

Recurring digestive issues like bloating, abdominal pain, or alternating diarrhoea and constipation can significantly impact your quality of life. Kijimea IBS Pro offers an innovative, clinically validated solution to address the root cause of these discomforts, helping to restore natural intestinal balance. This targeted medical device uses a unique scientific approach to soothe irritable bowel syndrome (IBS) symptoms, supporting long-term digestive comfort.

A targeted reparative action

The key to Kijimea’s effectiveness lies in its exclusive bifidobacteria strain, B. bifidum HI-MIMBb75, carefully selected for its protective properties. This strain acts like an intestinal bandage, adhering to the mucosal lining to promote natural regeneration. By repairing the microlesions responsible for inflammation and hypersensitivity, it significantly reduces functional digestive issues and helps restore balanced bowel function.

Unlike symptomatic treatments, this medical device targets the underlying cause of imbalance, delivering gradual and lasting improvement. Clinical studies confirm a marked reduction in typical IBS symptoms, with excellent long-term tolerability.

Proven efficacy and validated safety

The effectiveness of IBS Pro has been rigorously evaluated in a randomised clinical trial published in The Lancet Gastroenterology & Hepatology. Results confirm its beneficial effects in reducing abdominal pain, bloating, and bowel irregularities, with an impeccable safety profile. Designed for easy daily integration, this medical device works without interfering with ongoing treatments.

Manufactured to the highest standards, it meets all medical device requirements and carries CE marking, ensuring compliance and safety. Regular use helps maintain optimal digestive comfort and improved quality of life, without risk of dependency.

With Kijimea, choose a scientifically backed solution to soothe your gut and regain daily well-being and serenity.

Kijimea® IBS Pro – A medical device for treating irritable bowel syndrome (IBS) with typical symptoms of constipation, diarrhoea, abdominal pain, and bloating.
Clinically proven efficacy for irritable bowel syndrome[1]
[1] Andresen V. et al. (2020): Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol. 2020; 5: 658-666.